On May 23, 2025, Aptevo Therapeutics Inc. implemented a reverse stock split at a 1-for-20 ratio, following a shareholder approval on May 14, 2025, resulting in 20 shares combined into 1 share without affecting ownership percentages. The new trading for shares will begin on May 27, 2025.